- Investing Ideas
- /
- Global Top Stock Picks from Analysts
Global Top Stock Picks from Analysts
Results
4590
Companies which are more than 50% undervalued based on analyst price target.
4,590 companies
AEON Biopharma
Market Cap: US$734.7k
A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
AEON
US$0.66
7D
-28.1%
1Y
-99.9%
Bio-Path Holdings
Market Cap: US$713.2k
Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.
BPTH
US$0.17
7D
-1.4%
1Y
-96.6%
TC Biopharm (Holdings)
Market Cap: US$710.0k
A clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform.
TCBP
US$1.73
7D
0%
1Y
-99.3%
Biora Therapeutics
Market Cap: US$707.7k
A clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.
BIOR.Q
US$0.16
7D
20.0%
1Y
-98.6%
Nature's Miracle Holding
Market Cap: US$625.2k
An agriculture technology company, provides lighting and grow media products to growers in the controlled environment agriculture industry in the United States and Canada.
NMHI
US$0.23
7D
-13.2%
1Y
-99.5%
WntResearch
Market Cap: SEK 6.1m
A biotech company, develops therapies to prevent the metastatic process.
WNT
SEK 0.70
7D
-12.5%
1Y
n/a
Altamira Therapeutics
Market Cap: US$559.0k
Operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia.
CYTO.F
US$0.12
7D
2.9%
1Y
-92.9%
Chesterfield Resources
Market Cap: UK£423.6k
Engages in the exploration and development of precious and base metals in Cyprus, Canada, and the United Kingdom.
CHF
UK£0.0032
7D
-7.1%
1Y
-27.8%
TransCode Therapeutics
Market Cap: US$541.5k
A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.
RNAZ
US$0.78
7D
-43.2%
1Y
-96.5%
LungLife AI
Market Cap: UK£367.9k
A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.
LLAI
UK£0.012
7D
-14.3%
1Y
-95.8%
Windtree Therapeutics
Market Cap: US$453.0k
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$2.05
7D
12.9%
1Y
-99.3%
Scandion Oncology
Market Cap: SEK 4.1m
A clinical-stage biotechnology company, discovers and develops medicines for the treatment of cancer.
SCOL
SEK 0.018
7D
6.1%
1Y
-99.2%
LogicMark
Market Cap: US$360.4k
Provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States.
LGMK
US$0.18
7D
-4.9%
1Y
-99.3%
Spineway
Market Cap: €85.8k
Engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column.
ALSPW
€0.10
7D
1.4%
1Y
-95.3%
Ngenic
Market Cap: SEK 776.4k
Provides digitalized energy services for consumers, property owners, and energy companies in Sweden.
NGENIC
SEK 0.11
7D
2.2%
1Y
-98.6%
G Medical Innovations Holdings
Market Cap: US$52.9k
An early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel.
GMVD.F
US$0.0002
7D
0%
1Y
-98.2%
Eigenheim Union 1898 Beteiligungs
Market Cap: €42.1k
Operates as a real estate development company in Germany.
JZ6
€0.022
7D
-72.9%
1Y
-98.6%
Zapata Computing Holdings
Market Cap: US$19.3k
Operates as an industrial generative artificial intelligence (AI) software company in the United States.
ZPTA
US$0.0005
7D
25.0%
1Y
-100.0%